221 related articles for article (PubMed ID: 9810003)
1. Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants.
Burow ME; Weldon CB; Tang Y; Navar GL; Krajewski S; Reed JC; Hammond TG; Clejan S; Beckman BS
Cancer Res; 1998 Nov; 58(21):4940-6. PubMed ID: 9810003
[TBL] [Abstract][Full Text] [Related]
2. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha sensitizes prostate cancer cells to gamma-irradiation-induced apoptosis.
Kimura K; Bowen C; Spiegel S; Gelmann EP
Cancer Res; 1999 Apr; 59(7):1606-14. PubMed ID: 10197636
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of transforming growth factor beta signaling in MCF-7 cells results in resistance to tumor necrosis factor alpha: a role for Bcl-2.
Tobin SW; Brown MK; Douville K; Payne DC; Eastman A; Arrick BA
Cell Growth Differ; 2001 Feb; 12(2):109-17. PubMed ID: 11243465
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
[TBL] [Abstract][Full Text] [Related]
6. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
7. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Kazhdan I; Marciniak RA
Cancer Gene Ther; 2004 Oct; 11(10):691-8. PubMed ID: 15354201
[TBL] [Abstract][Full Text] [Related]
8. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Ravi R; Bedi A
Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
[TBL] [Abstract][Full Text] [Related]
9. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
[TBL] [Abstract][Full Text] [Related]
12. Distinct stress and cell destruction pathways are engaged by TNF and ceramide during apoptosis of MCF-7 cells.
Donato NJ; Klostergaard J
Exp Cell Res; 2004 Apr; 294(2):523-33. PubMed ID: 15023539
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.
Mathiasen IS; Lademann U; Jäättelä M
Cancer Res; 1999 Oct; 59(19):4848-56. PubMed ID: 10519395
[TBL] [Abstract][Full Text] [Related]
14. Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells.
Katschinski DM; Robins HI; Schad M; Frede S; Fandrey J
Cancer Res; 1999 Jul; 59(14):3404-10. PubMed ID: 10416602
[TBL] [Abstract][Full Text] [Related]
15. Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation.
Chen T; Wong YS
Int J Biochem Cell Biol; 2009 Mar; 41(3):666-76. PubMed ID: 18718551
[TBL] [Abstract][Full Text] [Related]
16. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
Suliman A; Lam A; Datta R; Srivastava RK
Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
[TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells.
Wang Q; Maloof P; Wang H; Fenig E; Stein D; Nichols G; Denny TN; Yahalom J; Wieder R
Exp Cell Res; 1998 Jan; 238(1):177-87. PubMed ID: 9457070
[TBL] [Abstract][Full Text] [Related]
18. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.
Lane D; Cartier A; L'Espérance S; Côté M; Rancourt C; Piché A
Gynecol Oncol; 2004 Jun; 93(3):594-604. PubMed ID: 15196850
[TBL] [Abstract][Full Text] [Related]
19. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death.
Meslin F; Hamaï A; Gao P; Jalil A; Cahuzac N; Chouaib S; Mehrpour M
Cancer Res; 2007 Nov; 67(22):10910-9. PubMed ID: 18006836
[TBL] [Abstract][Full Text] [Related]
20. The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.
Ruiz de Almodóvar C; Ruiz-Ruiz C; Muñoz-Pinedo C; Robledo G; López-Rivas A
Oncogene; 2001 Oct; 20(48):7128-33. PubMed ID: 11704839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
